This technology is a specialized mouse diet that selectively induces ferroptosis in tumors in vivo to suppress tumor growth while preserving normal tissue function.
\r\rCurrent approaches to induce ferroptosis in cancer primarily rely on small-molecule agents or genetic modulation, which often lack tumor selectivity and can lead to systemic toxicity like weight loss and organ failure in mice. Additionally, many strategies demonstrate efficacy in vivo but fail to translate effectively in vivo due to delivery limitations and off-target effects. There remains a need for approaches that can safely and selectively enhance ferroptosis within tumors while minimizing damage to normal tissues and organs in an in vivo system.
\r\rThis technology is a specialized dietary formulation, termed Harmonic chow, that modulates the in vivo metabolic environment to promote ferroptosis in tumor cells. Tumor cells, which often exhibit elevated iron levels and oxidative stress, are more susceptible to ferroptosis. In contrast, normal tissues maintain tighter regulation of redox balance, enabling selective targeting without widespread toxicity. By enhancing tumor sensitivity to ferroptosis, this approach provides a non-invasive strategy to suppress tumor growth and may enhance the efficacy of anticancer therapies.
\r\rThis technology has been validated in tumor-bearing mice. In tumor-bearing mouse models, administration of Harmonic chow reduced tumor volume without causing chronic weight loss.
\r\rIR CU26233
Licensing Contact: Joan Martinez